ClinicalTrials.gov record
Suspended Phase 4 Interventional

Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age

ClinicalTrials.gov ID: NCT00646893

Public ClinicalTrials.gov record NCT00646893. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of Embryo Transfer With and Without PGS for the Indication of Advanced Reproductive Age (37-42) in Patients Undergoing ART

Study identification

NCT ID
NCT00646893
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 4
Lead sponsor
Reprogenetics
Industry
Enrollment
1,200 participants

Conditions and interventions

Conditions

Interventions

  • Preimplantation Genetic Diagnosis (PGD) Procedure

Procedure

Eligibility (public fields only)

Age range
37 Years to 42 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Dec 31, 2010
Completion
Mar 31, 2011
Last update posted
Feb 22, 2010

2008 – 2011

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
ART Reproductive Center, Beverly Hills California 90210
Fertility Centers of Illinois Highland Park Illinois 60035
Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center Livingston New Jersey 07039
Reprogenetics Livingston New Jersey 07039

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00646893, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2010 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00646893 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →